Global PRMT5 Targeted Therapy Market & Clinical Trials Insights 2024: Innovation and Potential in Oncology and Beyond
February 29, 2024 04:06 ET
|
Research and Markets
Dublin, Feb. 29, 2024 (GLOBE NEWSWIRE) -- The "Global PRMT5 Targeted Therapy Market & Clinical Trials Opportunity Outlook 2024" report has been added to ResearchAndMarkets.com's offering. ...
China Oncology Drugs Market Report, 2023 and 2024-2028 - Cancer Prevention Takes Center Stage in China's National Health Agenda
February 19, 2024 07:48 ET
|
Research and Markets
Dublin, Feb. 19, 2024 (GLOBE NEWSWIRE) -- The "China Oncology Drugs Market, Size, Forecast 2024-2028, Industry Trends, Share, Growth, Insight, Impact of Inflation, Company Analysis" report has been...
Head and Neck Cancer Therapeutics Market to Reach $2.3 Billion by 2027 - New Research Report Reveals
January 24, 2024 13:26 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Head and Neck Cancer Therapeutics Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The latest research report...
Global Thyroid Cancer Drugs Market Report 2024: Highlights Trends in Targeted Therapies, Featuring Profiles of Mylan Pharmaceuticals, AstraZeneca, Exelixis, Pfizer, and Bristol-Myers Squibb
January 23, 2024 15:28 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Thyroid Cancer Drugs Global Market 2024" report has been added to ResearchAndMarkets.com's offering. The global thyroid cancer drugs market...
Chemotherapy Induced Peripheral Neuropathy Treatment Market to Surge to $2.06 Billion by 2027, New Research Shows
January 23, 2024 02:38 ET
|
Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The...
Comprehensive Analysis of the Global Chemotherapy Market, 2018-2033: Digital Health and AI are Revolutionizing Cancer Care
January 18, 2024 06:58 ET
|
Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global chemotherapy market has grown rapidly in...
Pleco Therapeutics receives FDA Orphan Drug Designation
January 16, 2024 11:30 ET
|
Pleco Therapeutics B.V.
The U.S Food and Drug Administration (FDA) has granted Orphan Drug Designation to Pleco Therapeutics BV’s lead compound, PTX-252 for the treatment of AML.
Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030
January 09, 2024 10:25 ET
|
FN Media Group LLC
PALM BEACH, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - According to the report titled "Aging in the United States," published by the Population Reference Bureau, "the...
Largest study to date of high-dose methotrexate associated acute kidney injury supports the use of Voraxaze® (glucarpidase)
December 11, 2023 09:51 ET
|
BTG Specialty Pharmaceuticals
West Conshohocken, PA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- BTG Pharmaceuticals, a SERB company, announces the presentation of the largest study to date of patients with high-dose methotrexate (HDMTX)...
United States Liver Cancer Therapeutics Research Report 2023: Markets, Competition, Forecast and Opportunities, 2018-2028
December 07, 2023 11:08 ET
|
Research and Markets
Dublin, Dec. 07, 2023 (GLOBE NEWSWIRE) -- The "United States Liver Cancer Therapeutics Market, Competition, Forecast and Opportunities, 2018-2028" report has been added to ResearchAndMarkets.com's...